申请人:——
公开号:US20040138301A1
公开(公告)日:2004-07-15
This invention relates to chemical uncouplers with a broader safety window making the use of them in treating obesity and, consequently, in the treatment of obesity related diseases and conditions such as atherosclerosis, hypertension, diabetes, especially type 2 diabetes (NIDDM (non-insulin dependent diabetes mellitus)), impaired glucose tolerance, dyslipidemia, coronary heart disease, gallbladder disease, osteoarthritis and various types of cancer such as endometrial, breast, prostate and colon cancers and the risk for premature death as well as other conditions, such as diseases and disorders, which conditions are improved by an increase in mitochondrial respiration, more attractive.
本发明涉及具有更广泛安全窗口的化学解偶联剂,使得它们在治疗肥胖症方面的应用更加安全,因此在治疗肥胖相关疾病和病况,如动脉硬化、高血压、糖尿病,尤其是2型糖尿病(NIDDM(非胰岛素依赖性糖尿病))、糖耐量受损、血脂异常、冠心病、胆囊疾病、骨关节炎以及各种类型的癌症,如子宫内膜癌、乳腺癌、前列腺癌和结肠癌以及早逝的风险等其他病况、疾病和障碍,通过提高线粒体呼吸作用而得到改善。